Responding to the emergence of new scientific evidence, WHO is in the process of developing a revised and consolidated set of guidelines related to the use of ARVs for HIV treatment and prevention. These will prioritise people who are most at risk and aim to accelerate progress towards universal access to HIV diagnostics, treatment, care and support.
The guidelines are planned for release in early 2013 - previous versions can be found here.
Recognising it is critical that the guidelines reflect the realities of the lives of people and communities living with and affected by HIV, and of civil society, WHO seeks to undertake a consultative process with communities to inform their guidelines.
As a result, the Alliance and the Global Network of People Living with HIV (GNP+), in collaboration with WHO, are conducting an online e-survey and several e-forum discussions to gather feedback in a number of areas.
Gitau Mburu, the Alliance’s Senior Technical Advisor on Health Systems and Services, said: “This is an important project. The new guidance will have implications for the future of HIV programming and it is vital that as many civil society and community representatives as possible share their experiences and knowledge about HIV treatment so that the final guidelines fully reflect the realities of people’s lives.
Find out how you can take part here.